The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors.
 
Runbo Zhong
No Relationships to Disclose
 
Min Yan
No Relationships to Disclose
 
Qiming Wang
No Relationships to Disclose
 
Huangming Hong
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Man Hu
No Relationships to Disclose
 
Qiongyu Lan
No Relationships to Disclose
 
Yongzhong Luo
No Relationships to Disclose
 
Ling Zhang
No Relationships to Disclose
 
Jinhua Wen
No Relationships to Disclose
 
Haipeng Xu
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Hongxia Lu
No Relationships to Disclose
 
Sanxing Guo
No Relationships to Disclose
 
Longzhen Zhang
No Relationships to Disclose
 
Lin Wu
No Relationships to Disclose
 
Jie Ma
No Relationships to Disclose
 
Xiao Li
Employment - Jiangsu Hengrui Pharmaceuticals, Co., Ltd
 
Yanhua Huang
Employment - Jiangsu Hengrui Pharmaceuticals, Co., Ltd
 
Hua Zhong
No Relationships to Disclose